Mehta Japan, an insider at Humana Inc (HUM), sold 8,158 shares of company stock on December 14, 2025, at a price of $270.15 per share, totaling $2.20 million. Following this transaction, Japan retains 8,158 shares of Humana.
This sale reflects a common practice among insiders, who may sell shares for various reasons, including diversification, tax planning, or personal financial needs. While significant insider selling can attract investor scrutiny, routine transactions do not necessarily indicate negative sentiment toward the company.
Insider trades are required to be reported to the SEC, providing transparency into how executives and board members view their holdings. However, selling activity by a single insider is just one data point for investors to consider. It is advisable to examine patterns of insider activity across multiple insiders and time periods for a more comprehensive understanding of market sentiment.
Humana Inc operates in the health care sector, providing health insurance services and employing 65,680 full-time staff. The company is headquartered in Louisville, Kentucky, and its business segments include Insurance and CenterWell. The Insurance segment encompasses Medicare benefits and Medicaid services, while CenterWell focuses on pharmacy and primary care operations.
As of December 18, 2025, Humana's market capitalization stands at $31.7 billion, with a P/E ratio of 24.59 and an EPS of 10.67. The company has a dividend yield of 136.0%. Upcoming earnings are scheduled for July 28, 2026, with an estimated EPS of $5.29 and revenue of $36.9 billion, followed by another report on April 28, 2026, with an estimated EPS of $10.71 and revenue of $36.1 billion.